Registration Dossier
Registration Dossier
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 219-708-8 | CAS number: 2503-73-3
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data

Endpoint summary
Administrative data
Key value for chemical safety assessment
Genetic toxicity in vitro
Description of key information
In Vitro Mammalian Cell Micronucleus Test assayed genotoxicity of the test substance, Direct Blue 78. The test was performed according to OECD Test Guideline No. 487 -In Vitro Mammalian Cell Micronucleus Test, Adopted 26thSeptember, 2014.
The test substance Direct Blue 78 was assayed for the mutagenicity by the Bacterial Reverse Mutation Test. The performed test was based on EU method B.13/14 Mutagenicity – Reverse mutation test using bacteria,which is analogous to the OECD Test Guideline No. 471.
The test substance,Direct Blue 78,was assayed for the mutagenicity by the In Vitro Mammalian Cell Gene Mutation Test. The performed test was based on OECD Test Guideline No. 476–In VitroMammalian Cell Gene Mutation Test(2015),which is analogous to the EU methodB.17. V79 hamster fibroblast were used for testing.
These studies are GLP and Klimish score 1.
Link to relevant study records
- Endpoint:
- in vitro gene mutation study in mammalian cells
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- 03.05.-01.07.2016
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- guideline study
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 487 (In vitro Mammalian Cell Micronucleus Test)
- Deviations:
- yes
- Remarks:
- See any other information...
- GLP compliance:
- yes (incl. QA statement)
- Type of assay:
- in vitro mammalian cell micronucleus test
- Species / strain / cell type:
- mammalian cell line, other:
- Remarks:
- peripheral blood lymphocytes mammalian cell line
- Details on mammalian cell type (if applicable):
- The human peripheral blood lymphocytes used for testing were obtained from healthy non smokingdonors (up to 35 years of age). Peripheral blood (heparinized) is taken from donors in certified medicallaboratory (MeDiLa) in the morning and as soon as possible transported into the test facility.
- Metabolic activation:
- with and without
- Metabolic activation system:
- S9 fraction of rat liver homogenate and mixture of cofactors
- Untreated negative controls:
- yes
- Positive controls:
- yes
- Positive control substance:
- cyclophosphamide
- other: Colchicine
- Details on test system and experimental conditions:
- Principle of test is the detection of binucleated cells with micronuclei, which are induced by the test substance in human peripheral blood lymphocytes. Lymphocytes are cultured in growth medium and test substance is added to them. Cell cycle is then stopped by cytochalasin B, cultures are sampled and microscopic preparations are prepared. Preparations are then analysed by microscope. Genotoxicity is indicated by increased incidence of binucleated cells with micronuclei.Experiments with and without metabolic activation with short treatment (3 hours) are done at first. If both experiments with the short treatments are negative or equivocal, subsequently, extended exposure treatment without metabolic activation is performed.
- Key result
- Species / strain:
- mammalian cell line, other: peripheral blood lymphocytes
- Metabolic activation:
- with and without
- Genotoxicity:
- negative
- Cytotoxicity / choice of top concentrations:
- no cytotoxicity
- Vehicle controls validity:
- valid
- Untreated negative controls validity:
- valid
- Positive controls validity:
- valid
- Additional information on results:
- Results overviewResults of experiments are summarized in the tables in the Annexes 1 (cytotoxicity) and 2 (genotoxicity). The tables contain the dose applied per culture in µg/mL (concentrations of test substance were applied to cultures at a volume of 50 µl), amount of S9 per culture in µl, number of mononucleated, binucleated and multinucleated cells, CBPI index and % cytotoxicity, numbers of binucleated cells with micronuclei and average numbers of binucleated cells with micronuclei in 1000 cells, number of micronuclei and average number of micronuclei in 1000 cells, parameter Mt / Mc, i.e. ratio of number of binucleated cells with micronuclei at tested dose (Mt) to number of binucleated cells with micronuclei at negative control (Mc, UTC or S9-mix). Numbers of binucleated cells with micronuclei in negative and positive controls were compared with historical controls in our laboratory. The current ranges are given in Annex 3 (Table 7 and Table 8). Values of negative and positive controls in this study are within the ranges of historical data, so that test system responds adequately and the experiment is acceptable.The cytotoxic effect was characterized as % of cytotoxicity. Results of the cytotoxic effect are given in the Table 1 - 3 (Annex 1). All of test concentrations did not show the cytotoxicity higher than 55±5 % in the time of exposure 3 hours. The second experiment with the prolonged exposition without activation (23 hours) gave in three tested concentrations (2000, 1000 and 500 µg/mL) high cytotoxicity (small and dark cells) therefore microscopic slides could not be analyzed for cytotoxicity and genotoxicity. The concentrations 250 µg/mL was evaluated only for cytotoxicity, but could not be used for genotoxicity evaluation because of poor appearance of microscopic slides (small and dark cells). On the basis of these results, the third experiment without metabolic activation with extended exposure and lower concentrations 125, 62.5 and 31.25 µg/mL had to be done. In the third experiment with the prolonged exposition without activation (23 hours), all of tested concentrations did not show the cytotoxicity higher than 55±5 %. Therefore the concentration of 125 µg/mL was selected as the highest one for the analysis of genotoxic effect.
- Conclusions:
- Under the experimental design described above, the test substance, Direct Blue 78, had no genotoxic effects in the micronucleus test performed in human peripheral blood lymphocytes in experiments both without and with metabolic activation.The result of micronucleus test was negative, test substance is then considered not able to induce chromosome breaks and/or chromosome gain or loss in this test system.
- Executive summary:
In Vitro Mammalian Cell Micronucleus Test assayed genotoxicity of the test substance, Direct Blue 78. The test was performed according to OECD Test Guideline No. 487 -In Vitro Mammalian Cell MicronucleusTest, Adopted 26thSeptember, 2014.
The human peripheral blood lymphocytes from healthy donors were used for testing. The test substance was suspended in RPMI medium and assayed in five concentrations 31.25-2000 µg/mL, which were applied to cultures in volume of 50 mL.
Experiments were performed without as well as with metabolic activation with a supernatant of rat liver and a mixture of cofactors.
Under the experimental design described above, the test substance, Direct Blue 78,had no genotoxic effects in the micronucleus test performed in human peripheral blood lymphocytesin experiments both without and with metabolic activation.
The result of micronucleus test was negative, test substance is then considered not able to induce chromosome breaks and/or chromosome gain or loss in this test system.- Endpoint:
- in vitro gene mutation study in bacteria
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- 16.02.-24.03.2016
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- guideline study
- Qualifier:
- according to guideline
- Guideline:
- EU Method B.13/14 (Mutagenicity - Reverse Mutation Test Using Bacteria)
- Deviations:
- yes
- Remarks:
- A deviation was observed in TA 1535 the second experiment with metabolic activation: average mumber of revertants in positive control was 270 while maximum in historical control range is 264.
- GLP compliance:
- yes (incl. QA statement)
- Type of assay:
- bacterial reverse mutation assay
- Target gene:
- gene for histidine or tryptophan synthesis
- Species / strain / cell type:
- S. typhimurium TA 1535, TA 1537, TA 98 and TA 100
- Species / strain / cell type:
- E. coli WP2 uvr A
- Metabolic activation:
- with and without
- Metabolic activation system:
- supernatant of rat liver and a mixture of cofactors.
- Test concentrations with justification for top dose:
- 50, 150, 500, 1500, 5000 μg30, 100, 300, 1000, 3000 μgSelection of doses/toxicity: 2 mL of water for injection was added to 100 mg of the test substance toreach the maximum dose recommended in guidelines - 5000 μg per plate
- Vehicle / solvent:
- Water for injection, Ardeapharma, Lot. No.: 1501210041, exp. 01/2017- Justification for choice of solvent/vehicle: solubility of the substance
- Untreated negative controls:
- yes
- Negative solvent / vehicle controls:
- yes
- Positive controls:
- yes
- Positive control substance:
- sodium azide
- other: 4-nitro-o-phenylenediamine, 2-aminofluorene, 2-aminoanthracene, N-methyl-N´-nitro-N-nitrosoguanidine, 9-aminoacridine hydrochloride monohydrate
- Details on test system and experimental conditions:
- The bacterial tester strains Salmonella typhimurium TA 1535 (CCM 3814, lot. No. 2101200916917), TA 98 (CCM 3811, lot No. 01022001220053), TA 100 (CCM 3812, lot No. 0102201220054) and TA 1537 (CCM 3815, lot No. 2101200916918) as well as Escherichia coli WP2 uvrA (CCM 4751, lot No. 2104200512732), - were obtained from Czech Collection of Microorganisms (CCM) of Masaryk University, Brno.Strains TA 98 and TA 1537 detect frame shift mutations, strains TA 100 and TA 1535 serve to detectionof base-pair substitution mutations, and strain E.coli WP2 uvrA detects cross-linking mutagensMETHOD OF APPLICATION: in agar (plate incorporation)NUMBER OF REPLICATIONS: two seriesDETERMINATION OF CYTOTOXICITY- Method: relative total growth
- Evaluation criteria:
- The main criterion for evaluation of results was modified two-fold increase rule, which is compatible withthe application of statistical methods (2, 3). After this rule the result is positive, if a reproducible doseresponseeffect occurs and/or a doubling of the ratio Rt/Rc is reached.
- Statistics:
- For the evaluation of results, the modified two-fold increase rule was used, which is compatible with theapplication of statistical methods:Dunkel V. C.. Chu K.C. (1980): Evaluation of methods for analysis of microbial mutagenicity assays. inThe Predictive Value of Short-Term Screening Tests in Carcinogenicity Evaluation. Elsevier North-Holland Biomedical Press. 231 - 417Claxton L. D. et al. (1987): Guide for the Salmonella typhimurium/mammalian microsome tests forbacterial mutagenicity. Mutat. Res. 189. 83 - 91
- Key result
- Species / strain:
- S. typhimurium TA 1535
- Metabolic activation:
- with and without
- Genotoxicity:
- negative
- Cytotoxicity / choice of top concentrations:
- not determined
- Vehicle controls validity:
- valid
- Untreated negative controls validity:
- valid
- Positive controls validity:
- valid
- Key result
- Species / strain:
- S. typhimurium TA 98
- Metabolic activation:
- with and without
- Genotoxicity:
- negative
- Cytotoxicity / choice of top concentrations:
- no cytotoxicity
- Vehicle controls validity:
- valid
- Untreated negative controls validity:
- valid
- Positive controls validity:
- valid
- Key result
- Species / strain:
- S. typhimurium TA 100
- Metabolic activation:
- with and without
- Genotoxicity:
- negative
- Cytotoxicity / choice of top concentrations:
- not determined
- Vehicle controls validity:
- valid
- Untreated negative controls validity:
- valid
- Positive controls validity:
- valid
- Key result
- Species / strain:
- S. typhimurium TA 1537
- Metabolic activation:
- with and without
- Genotoxicity:
- negative
- Cytotoxicity / choice of top concentrations:
- not determined
- Vehicle controls validity:
- valid
- Untreated negative controls validity:
- valid
- Positive controls validity:
- valid
- Key result
- Species / strain:
- E. coli WP2 uvr A
- Metabolic activation:
- with and without
- Genotoxicity:
- negative
- Cytotoxicity / choice of top concentrations:
- not determined
- Vehicle controls validity:
- valid
- Untreated negative controls validity:
- valid
- Positive controls validity:
- valid
- Additional information on results:
- THISTORICAL CONTROL DATAEach experiment included corresponding positive (reference mutagens) and negative controls (untreatedcontrol, solvent control). Untreated controls contain no solvent and negative controls contain 0.1 mL ofwater for injection. All the control numbers were compared with historical ranges of mutant frequenciesobtained in our laboratory. The actual numbers were in ranges of the historical numbers.ADDITIONAL INFORMATION ON CYTOTOXICITY:For toxicity experiment, the starting solution (5000 μg/0.1 mL) was diluted to concentration series 10 –5000 μg per plate. The concentration row was tested for toxicityin strain TA 98 without metabolic activation.No toxicity of the test substance or precipitation was observed at evaluation so the dose of 5000 μgper plate was used as maximum for the first mutagenicity experiments as well. The maximum concentration was diluted according to the rules given in guidelines (five different analysable concentrations withapproximately half log ,i.e. approximately #10, intervals between test points). The doses used were 50,150, 500, 1500 and 5000 μg per plateApplicant's summary and co
- Conclusions:
- Under the above-described experimental design, the test substance, Direct Blue 78, was non mutagenic for all the Salmonella typhimurium as well as Escherichia coli strains with as well as without metabolic activation.
- Executive summary:
The test substance Direct Blue 78 was assayed for the mutagenicity by the Bacterial Reverse Mutation Test. The performed test was based on EU method B.13/14 Mutagenicity – Reverse mutation test using bacteria,which is analogous to the OECD Test Guideline No. 471.
Four indicator Salmonella typhimuriumstrains TA 98, TA 100, TA 1535, TA 1537 and one indicator Escherichia coli WP2 uvrA strain were used. The test substance was diluted in water for injection and assayed in doses of 30-5000mg per plate, which were applied to plates in volume of 0.1 mL.
Experiments were performed without as well as with metabolic activation with a supernatant of rat liver and a mixture of cofactors.
In the arrangement given above, thetest substance, Direct Blue 78, was non-mutagenicfor all the used tester strainswithout as well as with metabolic activation.
- Endpoint:
- in vitro gene mutation study in mammalian cells
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- 17.08.-13.10.2016
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- guideline study
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 476 (In Vitro Mammalian Cell Gene Mutation Test)
- Deviations:
- yes
- Remarks:
- See Any other...
- GLP compliance:
- yes (incl. QA statement)
- Type of assay:
- other: mammalian cell gene mutation assay
- Target gene:
- HPRT
- Species / strain / cell type:
- Chinese hamster lung fibroblasts (V79)
- Details on mammalian cell type (if applicable):
- Frozen permanent cell culture was obtained from European Collection of Cell Cultures (ECACC). V79 used for experiments: Lot. No.: 10H016. ECACC
- Metabolic activation:
- with and without
- Metabolic activation system:
- S9 fraction of rat liver homogenate and mixture of cofactors.
- Untreated negative controls:
- yes
- Negative solvent / vehicle controls:
- yes
- Positive controls:
- yes
- Positive control substance:
- 7,12-dimethylbenzanthracene
- ethylmethanesulphonate
- Details on test system and experimental conditions:
- The lung fibroblasts V79 from male Chinese hamster were used for testing.Frozen permanent cell culture was obtained from European Collection of Cell Cultures (ECACC). V79 used for experiments: Lot. No.: 10H016. ECACC Certificate of Analysis is a part of archived study documentation. The cells were kept at -196 ºC under liquid nitrogen. After activation, cells are grown in DMEM medium with L-glutamine and 10 % FBS in incubator (5 % CO2, 37±1 °C, moistened).Cells underwent maximum 5 passages after thawing the original culture delivered from cell collection before using for test. Cleansing of cultures was performed 5 days before treatment with complete medium supplemented with HAT supplement due to elimination of mutants. Cleansing was not performed in experiment without metabolic activation, because of bad growth of cells in HAT medium.The test substance was then diluted in DMEM. According to the recommendation in the OECD Guideline the maximum concentration used for experiment without metabolic activation was 2 mg·mL-1. The other concentrations were 1.0, 0.5, 0.25 mg·mL-1.At observation after almost 3 hours presence of the undiluted test substance was found in medium, so the maximum concentration was abolished and it was replaced by the dose of 0.125 mg·mL-1. In the test with metabolic activation, the same concentrations (0.125-1.0 mg·mL-1) were used.Concentrations for the experiment without metabolic activation were stated on the base of solubility/Guideline recommendation and were 0.25, 0.5, 1.0 and 2.0 mg.mL-1. Precipitation was observed in the dose of 2.0 mg.mL-1, so the highest dose was omitted and replaced by the dose of 0.125 mg.mL-1. No toxicity or precipitation was observed in the test without metabolic activation, so the same doses were used in experiment with metabolic activation. Every dish with negative control/test substance contained 1.0 mL of application form of the test substance in DMEM so that the final concentrations on dishes were as given above and 9.0 mL of complete medium or activation mixture (S9 mix) - for details see par 3.7.Cells were treated for 3 hours (with as well as without metabolic activation; day 1). After treatment, approximately 2*106 cells were transferred to suitable number of dishes to seed enough cells. At the same time, cells were seeded for detection of number of cells (PE estimation). On the 3rd, 6th and 8th day, approximately 2*106 cells from every culture were transferred and 10th day, extractions of mutants was performed with using selective medium together with PE estimation again (for details see Table 1).Determination of survivalAfter treatment period, the cultures were trypsinised and an aliquot (0.3 mL of 103/mL cell suspension) was diluted and plated to 6 cm Petri dishes to estimate the viability of the cells. A number of cells were then replaced in order to maintain the treated cell populations; the number of cells taken forward was adjusted according to the expected viability of the cultures, to give two millions of viable cells. Cells were grown in 10 cm Petri dishes.SubculturingOn the 3rd, 6th and 8th day the cell populations were subcultured in order to maintain them in exponential growth. The number of cells taken forward was adjusted according to the expected viability, to give two millions viable cells seeded in 10 cm Petri dishes.Incubation, staining and scoring Survival and plating efficiency plates were incubated for at least six days (37±1ºC, 5% CO2, moistened) prior to scoring. Mutant plates were incubated for an appropriate period to ensure adequate colony size (about 10 days). After incubation, the plates were stained with methylene blue and colonies were scored.
- Evaluation criteria:
- Each experiment is evaluated separately using modified two-fold increase rule according to Claxton L.D. et al, Mutat. Res.,189, 83-91, 1987 (2). The mutagenic potential is indicated by increasing number of mutants in treated groups in comparison to the negative solvent control (modified two-fold increase rule and any of the results outside the distribution of the historical negative control data) and/or by dependence of increasing number of mutants on dose (dose-response relationship).There is no requirement for verification of a clearly positive or negative response.In cases when the response is neither clearly negative nor clearly positive than a repeat experiment possibly using modified experimental conditions (e.g. concentration spacing, other metabolic activation conditions i.e. S9 concentration or S9 origin) could be performed.
- Key result
- Species / strain:
- Chinese hamster lung fibroblasts (V79)
- Metabolic activation:
- with and without
- Genotoxicity:
- negative
- Cytotoxicity / choice of top concentrations:
- no cytotoxicity
- Vehicle controls validity:
- valid
- Untreated negative controls validity:
- valid
- Positive controls validity:
- valid
- Conclusions:
- Under the above-described experimental design. the test substance, Direct Blue 78, was non-mutagenic for V79 cells with as well as without metabolic activation.
- Executive summary:
The test substance, Direct Blue 78, was assayed for the mutagenicity by the In Vitro Mammalian Cell Gene Mutation Test. The performed test was based on OECD Test Guideline No. 476–In VitroMammalian Cell Gene Mutation Test (2015), which is analogous to the EU method B.17. V79 hamster fibroblast were used for testing.
The test substance was dissolved in DMEM. No toxicity was supposed, so the maximum recommended concentration (2 mg·mL-1) was used at first. This concentration produced precipitation in Petri dishes, so concentrations used in the both mutagenicity tests - without as well as with metabolic activation - were1.0, 0.5, 0.25, and 0.125 mg·mL-1. No toxicity was observed in any dose.
In the arrangement given above, the test substance,Direct Blue 78,wasnon-mutagenicfor V79 cells without as well as with metabolic activation.
Referenceopen allclose all
Cytotoxic effect
Table No. 1: Evaluation of cytotoxic effect without metabolic activation-3h exposure
- MA I | ||||||
Culture No. | Treatment/Test substance concentration | Number of MNC | Number of BNC | Number of MTNC | CBPI | Cytotoxicity (%) |
1 | UTC | 756 | 282 | 39 | 1.334 | 0.0 |
2 | 2000 μg/mL | 928 | 182 | 9 | 1.179 | 46.5 |
3 | 1000 μg/mL | 691 | 386 | 26 | 1.397 | -18.8 |
4 | 500 μg/mL | 811 | 348 | 55 | 1.377 | -12.9 |
5 | 250 μg/mL | 607 | 422 | 77 | 1.521 | -55.8 |
6 | 125 μg/mL | 707 | 290 | 56 | 1.382 | -14.2 |
13 | Colchicine | 857 | 176 | 76 | 1.296 | 11.5 |
Table No. 2: Evaluation of cytotoxic effect with metabolic activation (S9-mix) -3h exposure
+MA I | ||||||
Culture No. | Treatment/Test substance concentration | Number of MNC | Number of BNC | Number of MTNC | CBPI | Cytotoxicity (%) |
7 | S9-mix | 925 | 298 | 45 | 1.306 | 0.0 |
8 | 2000mg/mL + S9-mix | 923 | 204 | 16 | 1.206 | 32.5 |
9 | 1000mg/mL + S9-mix | 939 | 183 | 20 | 1.195 | 36.2 |
10 | 500mg/mL + S9-mix | 828 | 187 | 28 | 1.233 | 23.9 |
11 | 250mg/mL + S9-mix | 764 | 267 | 69 | 1.368 | -20.3 |
12 | 125mg/mL + S9-mix | 724 | 406 | 67 | 1.451 | -47.4 |
14 | Cyclophosphamide + S9-mix | 630 | 453 | 35 | 1.468 | -52.9 |
1 | UTC | 756 | 282 | 39 | 1.334 | -9.2 |
Table No. 3: Evaluation of cytotoxic effect without metabolic activation -23h exposure
- MA III | ||||||
Culture No. | Treatment/Test substance concentration | Number of MNC | Number of BNC | Number of MTNC | CBPI | Cytotoxicity (%) |
15 | UTC | 528 | 426 | 61 | 1.54 | 0.0 |
17 | 125 μg/mL | 642 | 338 | 54 | 1.43 | 20.1 |
18 | 62.5 μg/mL | 607 | 382 | 50 | 1.46 | 14.1 |
19 | 31.25 μg/mL | 603 | 497 | 47 | 1.52 | 4.6 |
16 | Colchicine | 823 | 256 | 67 | 1.34 | 37.0 |
Genotoxic effect
Table No. 4: Evaluation of genotoxicity without metabolic activation-3h exposure
Culture No. | Treatment/Test substance concentration | Number of binucleated cells with MN | Number of MN | Average number of BN cells with MN per 1000 binucleated cells | Average number of MN per 1000 binucleated cells | Mt/Mc |
1 | UTC | 22 | 24 | 11 | 12 | 1.00 |
2 | 2000mg/mL | 42 | 45 | 21 | 22.5 | 1.91 |
3 | 1000mg/mL | 15 | 17 | 7.5 | 8.5 | 0.68 |
4 | 500mg/mL | 35 | 40 | 17.5 | 20 | 1.59 |
13 | Colchicine | 273 | 323 | 136.5 | 161.5 | 12.41 |
Table No. 5:Evaluation ofgenotoxicitywith metabolic activation (S9-mix) -3h exposure
Culture No. | Treatment/Test substance concentration | Number of binucleated cells with MN | Number of MN | Average number of BN cells with MN per 1000 binucleated cells | Average number of MN per 1000 binucleated cells | Mt/Mc |
7 | S9-mix | 23 | 24 | 11.5 | 12 | 1.00 |
8 | 2000 mg/mL + S9-mix | 20 | 22 | 10 | 11 | 0.87 |
9 | 1000mg/mL + S9-mix | 20 | 21 | 10 | 10.5 | 0.87 |
10 | 500mg/mL + S9-mix | 24 | 25 | 12 | 12.5 | 1.04 |
1 | UTC | 22 | 24 | 11 | 12 | 0.96 |
14 | Cyclophosphamide + S9-mix | 58 | 64 | 29 | 32 | 2.52 |
Table No. 6: Evaluation of genotoxicity without metabolic activation- 23h exposure
Culture No. | Treatment/Test substance concentration | Number of binucleated cells with MN | Number of MN | Average number of binucleated cells with MN per 1000 binucleated cells | Average number of MN per 1000 binucleated cells | Mt/Mc |
15 | UTC | 17 | 18 | 8.5 | 9 | 1.00 |
17 | 125mg/mL | 20 | 21 | 10 | 10.5 | 1.18 |
18 | 62.5mg/mL | 22 | 23 | 11 | 11.5 | 1.29 |
19 | 31.25mg/mL | 26 | 29 | 13 | 14.5 | 1.53 |
16 | Colchicine | 50 | 55 | 25 | 27.5 | 2.94 |
Endpoint conclusion
- Endpoint conclusion:
- no adverse effect observed (negative)
Additional information
Justification for classification or non-classification
Based on the available data, the substance is not classified. All tests are negative.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.
